Rexahn Receives FDA Orphan Drug Designation for RX-3117 in Treatment of Pancreatic Cancer Sep 24, 2014
Rexahn Pharmaceuticals to Present at the 14th Annual Biotech in Europe Investor Forum for Global Partnering and Investment in Basel, Switzerland Sep 23, 2014
Rexahn Pharmaceuticals to Present at the BioPharm Americaâ„¢ 2014 in Boston, Massachusetts, USA Sep 16, 2014
Rexahn Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference on September 9, 2014 Sep 4, 2014
Rexahn Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Novel Targeted Cancer Drug Delivery Platform Sep 3, 2014
Rexahn Pharmaceuticals Reports Second Quarter 2014 Financial Results and Pipeline Update Aug 14, 2014
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors Jul 18, 2014